MEDITOX S.R.O - Czech Republic 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2013 0 11.474.821 531.401 2
2012 0 12.805.026 1.169.663 3
2011 0 5.999.998 333.556 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
ALLIED AUTOMATION LIMITED1
ALMAC DIAGNOSTICS LIMITED1
AMVAC1
AMVAC RESEARCH1
ARTTIC1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CORDEN PHARMA SWITZERLAND LLC1
DIAMOND BIOPHARM LIMITED1
EIDGENOESSISCHES DEPARTEMENT DES INNERN1
ETNA BIOTECH S R L1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
FORSCHUNGSVERBUND BERLIN EV1
GENERA ISTRAZIVANJA DRUSTVO S OGRANICENOM ODGOVORNOSCU ZA PROIZVODNJU BIOTEHNOLOSKIH PROIZVODA1
GOETEBORGS UNIVERSITET1
GOTOVAX AB1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG1
INSTITUT PASTEUR1
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR IBMC1
INSTITUTO DE SALUD CARLOS III1
ISTITUTO SUPERIORE DI SANITA1
KING'S COLLEGE LONDON1
KLINICKI BOLNICKI CENTAR SESTRE MILOSRDNICE USTANOVA1
KLINICKI CENTAR UNIVERZITETA U SARAJEVU1
LEAD DISCOVERY CENTER1
LINKOEPING UNIVERSITY1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDIZINISCHE UNIVERSITAET WIEN1
MICROBIOTEC1
MINERVA CONSULTING & COMMUNICATION1
OZ BIOSCIENCES1
PARTICLE SCIENCES INC1
PARTICULAR SCIENCES LTDPSCI1
PAUL REGULATORY SERVICES LIMITED1
RIBOTASK APS1
SGS VITROLOGY LIMITED1
SIGMOID PHARMA LIMITED1
SMARTMEDICO DOO1
SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET1
SWISS TROPICAL INSTITUTE1
SYNTHAUR OOO1
TELORMEDIX1
THE HEBREW UNIVERSITY OF JERUSALEM1
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN1
THE UNIVERSITY OF MANCHESTER1
TP211
UNIVERSIDAD AUTONOMA DE MADRID1
UNIVERSITA DEGLI STUDI DI SIENA1
UNIVERSITY OF AARHUS1
UNIVERSITY OF ABERDEEN1
UNIVERSITY OF BERGEN1
VICHEM CHEMIE RESEARCH1
VITAMFERO1

Constancy:

Total number of partners: 55
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 55
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2013-11-01Clinical Studies on a Multivalent Vaccine for Human Visceral Leishmaniasis MULEVACLINparticipant5.475.3648
2013-10-01"A “Universal” Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines" UNIVAXparticipant5.999.45711
2012-10-01Development of an oral Helicobacter Pylori vaccine HELICOVAXORparticipant1.303.00011
2012-10-01Microbicide Optimization Through Innovative Formulation for Vaginal and Rectal Delivery MOTIFparticipant5.818.9379
2012-01-01Novel Bone Morphogenetic Protein-6 Biocompatible Carrier Device for Bone Regeneration OSTEOGROWparticipant5.683.08911
2011-06-01Innovative anti-influenza drugs excluding viral escape ANTIFLUparticipant5.999.99811